FI954066A0 - Dihydro-2,3-bentsodiatsepiinijohdannaisten kiteinen muoto - Google Patents

Dihydro-2,3-bentsodiatsepiinijohdannaisten kiteinen muoto

Info

Publication number
FI954066A0
FI954066A0 FI954066A FI954066A FI954066A0 FI 954066 A0 FI954066 A0 FI 954066A0 FI 954066 A FI954066 A FI 954066A FI 954066 A FI954066 A FI 954066A FI 954066 A0 FI954066 A0 FI 954066A0
Authority
FI
Finland
Prior art keywords
dihydro
crystalline form
benzodiazepine derivatives
acetyl
methyl
Prior art date
Application number
FI954066A
Other languages
English (en)
Swedish (sv)
Other versions
FI954066A (fi
FI112489B (fi
Inventor
Benjamin Alan Anderson
Marvin Martin Hansen
Jeffrey Thomas Vicenzi
David Lee Varie
Jr Milton Joseph Zmijewski
Edward Grant Groleau
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/412,242 external-priority patent/US6329364B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI954066A0 publication Critical patent/FI954066A0/fi
Publication of FI954066A publication Critical patent/FI954066A/fi
Application granted granted Critical
Publication of FI112489B publication Critical patent/FI112489B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI954066A 1994-08-31 1995-08-30 (R)-7-asetyyli-5-(4-aminofenyyli)-8,9-dihydro-8-metyyli-7H-1,3-dioksolo[4,5-h][2,3]bentsodiatsepiinin kiteinen muoto FI112489B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US29864594 1994-08-31
US08/412,242 US6329364B1 (en) 1994-08-31 1995-03-28 Crystalline form of dihydro-2,3-benzodiazepine derivative
US41224295 1995-03-28

Publications (3)

Publication Number Publication Date
FI954066A0 true FI954066A0 (fi) 1995-08-30
FI954066A FI954066A (fi) 1996-03-01
FI112489B FI112489B (fi) 2003-12-15

Family

ID=26970796

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954066A FI112489B (fi) 1994-08-31 1995-08-30 (R)-7-asetyyli-5-(4-aminofenyyli)-8,9-dihydro-8-metyyli-7H-1,3-dioksolo[4,5-h][2,3]bentsodiatsepiinin kiteinen muoto

Country Status (20)

Country Link
EP (1) EP0699678B1 (fi)
JP (1) JP3449835B2 (fi)
CN (1) CN1073996C (fi)
AT (1) ATE262531T1 (fi)
AU (1) AU695424B2 (fi)
BR (1) BR9503843A (fi)
CA (1) CA2157248C (fi)
CZ (1) CZ288679B6 (fi)
DE (1) DE69532739T2 (fi)
DK (1) DK0699678T3 (fi)
ES (1) ES2214491T3 (fi)
FI (1) FI112489B (fi)
HK (1) HK1013820A1 (fi)
HU (1) HU223843B1 (fi)
IL (1) IL115102A (fi)
NO (1) NO309192B1 (fi)
NZ (1) NZ272898A (fi)
PL (1) PL181086B1 (fi)
PT (1) PT699678E (fi)
TR (1) TR199501070A2 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
JP2002514184A (ja) 1996-09-27 2002-05-14 ギルフォード ファーマスーティカルズ インコーポレイテッド Ｎａａｌａｄアーゼ組成物ならびに動物におけるグルタメート異常を治療する方法および神経活性をもたらす方法
DE69820081D1 (de) * 1997-08-12 2004-01-08 Egyt Gyogyszervegyeszeti Gyar 1-3 dioxolo/4.5-h//2,3-benzodiazepin derivate als ampa/kainate-rezeptor-hemmer
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219778B (hu) 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
CZ222195A3 (en) 1996-03-13
AU695424B2 (en) 1998-08-13
HUT72675A (en) 1996-05-28
CZ288679B6 (cs) 2001-08-15
NO953394L (no) 1996-03-01
AU3035795A (en) 1996-03-14
PT699678E (pt) 2004-07-30
CA2157248C (en) 2000-02-22
CA2157248A1 (en) 1996-03-01
NO309192B1 (no) 2000-12-27
PL310228A1 (en) 1996-03-04
JP3449835B2 (ja) 2003-09-22
CN1073996C (zh) 2001-10-31
CN1128264A (zh) 1996-08-07
HK1013820A1 (en) 1999-09-10
FI954066A (fi) 1996-03-01
ATE262531T1 (de) 2004-04-15
TR199501070A2 (tr) 1996-06-21
NZ272898A (en) 1996-12-20
JPH0881469A (ja) 1996-03-26
IL115102A (en) 1998-12-27
NO953394D0 (no) 1995-08-30
DE69532739D1 (de) 2004-04-29
BR9503843A (pt) 1996-09-10
EP0699678A1 (en) 1996-03-06
EP0699678B1 (en) 2004-03-24
IL115102A0 (en) 1995-12-08
FI112489B (fi) 2003-12-15
HU9502549D0 (en) 1995-10-30
DE69532739T2 (de) 2005-03-17
HU223843B1 (hu) 2005-02-28
DK0699678T3 (da) 2004-06-28
ES2214491T3 (es) 2004-09-16
PL181086B1 (pl) 2001-05-31

Similar Documents

Publication Publication Date Title
DE69108138D1 (de) Imidazopyridinderivate und ihre Verwendung.
NO904377L (no) Tricykliske karbapenemforbindelser.
FI953384A0 (fi) Uusi bentsolitiaditsiiniyhdiste, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset koostumukset
FI954066A (fi) Dihydro-2,3-bentsodiatsepiinijohdannaisten kiteinen muoto
FI954065A (fi) Dihydro-2,3-bentsodiatsepiinijohdannaisen fyysinen olomuoto
DE69617226D1 (de) Piperidinderivate.
MY118394A (en) Crystalline form of dihydro-2, 3-benzodiazepine derivative
FI890293A (fi) Foerfarande foer framstaellning av tioformamidderivat.
SE8901060D0 (sv) New compounds
AU7332996A (en) Therapeutics for thrombocytopenia
IL78625A0 (en) Furanone derivatives and their preparation
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung
ATE100449T1 (de) 1,3-dioxolan-benzoesaeure und derivate davon.